Skip to main content

Anthony Vecchione

By Anthony Vecchione | 04:54 pm | September 11, 2024
Highmark members with low back pain can now get a prescription for the VR company's FDA-cleared RelieVRx.  
By Anthony Vecchione | 01:34 pm | September 11, 2024
The pharma giant will integrate more than 20 AI algorithms from eight collaborators into its navify Digital Pathology enterprise software to help improve pathology workflows.  
By Anthony Vecchione | 05:33 pm | September 10, 2024
AlphaProteo was created to advance drug design and disease understanding by helping researchers configure high-strength proteins that bind to molecules.
By Anthony Vecchione | 02:04 pm | September 10, 2024
The alliance aims to mitigate the human and economic price related to the improper prescribing and dispensing of controlled substances.  
By Anthony Vecchione | 03:03 pm | September 09, 2024
The acquisition adds governance, risk and compliance capabilities for behavioral health firms to Kipu's platform. 
By Anthony Vecchione | 03:19 pm | September 06, 2024
Lingo tracks glucose in real time and delivers personal insights and coaching.
By Anthony Vecchione | 02:43 pm | September 06, 2024
The collaboration will leverage Genetic Leap's RNA-targeted AI platform to create genetic medicines against selected targets.  
By Anthony Vecchione | 02:13 pm | September 05, 2024
The company will use the funds to expand its SubtleSYNTH technology to include brain imaging.  
By Anthony Vecchione | 11:22 am | September 05, 2024
The technology marries advanced proficiency of full prescription hearing aids with the contemporary design of consumer earbuds.  
By Anthony Vecchione | 04:45 pm | September 03, 2024
The company will use the funds to expand its geographic reach and presence in life sciences.